Biochemical basis of cancer chemoprevention and/or chemotherapy with ginsenosides (Review)
- Authors:
- Joon-Seok Choi
- Kyung-Soo Chun
- Juthika Kundu
- Joydeb Kumar Kundu
-
Affiliations: College of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Republic of Korea, College of Pharmacy, Keimyung University, Daegu 704-701, Republic of Korea - Published online on: October 10, 2013 https://doi.org/10.3892/ijmm.2013.1519
- Pages: 1227-1238
This article is mentioned in:
Abstract
 |
 |
|
Choi KT: Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin. 29:1109–1118. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Shibata S: Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci. 16(Suppl): S28–S37. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kitagawa I, Taniyama T, Shibuya H, Noda T and Yoshikawa M: Chemical studies on crude drug processing. V. On the constituents of ginseng radix rubra (2): Comparison of the constituents of white ginseng and red ginseng prepared from the same Panax ginseng root. Yakugaku Zasshi. 107:495–505. 1987.(In Japanese). | |
|
Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T and Taniyama T: Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra. Yakugaku Zasshi. 103:612–622. 1983.(In Japanese). | |
|
Shin HR, Kim JY, Yun TK, Morgan G and Vainio H: The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 11:565–576. 2000. View Article : Google Scholar | |
|
Yun TK, Lee YS, Lee YH, Kim SI and Yun HY: Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci. 16(Suppl): S6–S18. 2001. | |
|
Nag SA, Qin JJ, Wang W, Wang MH, Wang H and Zhang R: Ginsenosides as anticancer agents: In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol. 3:252012.PubMed/NCBI | |
|
Qi LW, Wang CZ and Yuan CS: Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry. 72:689–699. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hofseth LJ and Wargovich MJ: Inflammation, cancer, and targets of ginseng. J Nutr. 137(Suppl 1): 183S–185S. 2007.PubMed/NCBI | |
|
Kim YS and Jin SH: Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma. Arch Pharm Res. 27:834–839. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Keum YS, Han SS, Chun KS, et al: Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res. 523–524:75–85. 2003.PubMed/NCBI | |
|
Kumar A, Kumar M, Panwar M, et al: Evaluation of chemopreventive action of Ginsenoside Rp1. Biofactors. 26:29–43. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bae JS, Park HS, Park JW, Li SH and Chun YS: Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling. J Nat Med. 66:476–485. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
He BC, Gao JL, Luo X, et al: Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/β-catenin signaling. Int J Oncol. 38:437–445. 2011.PubMed/NCBI | |
|
Liu TG, Huang Y, Cui DD, et al: Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer. 9:2502009. View Article : Google Scholar : PubMed/NCBI | |
|
Musende AG, Eberding A, Wood C, et al: Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy. Cancer Chemother Pharmacol. 64:1085–1095. 2009. View Article : Google Scholar | |
|
Hu C, Song G, Zhang B, et al: Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J Cell Mol Med. 16:96–106. 2012. View Article : Google Scholar | |
|
Wang W, Rayburn ER, Hang J, Zhao Y, Wang H and Zhang R: Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD. Lung Cancer. 65:306–311. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Rayburn ER, Zhao Y, Wang H and Zhang R: Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett. 278:241–248. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Zhang X, Qin JJ, et al: Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One. 7:e415862012.PubMed/NCBI | |
|
Wang W, Rayburn ER, Hao M, et al: Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate. 68:809–819. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lü JM, Weakley SM, Yang Z, Hu M, Yao Q and Chen C: Ginsenoside rb1 directly scavenges hydroxyl radical and hypochlorous acid. Curr Pharm Des. 18:6339–6347. 2012.PubMed/NCBI | |
|
Park HM, Kim SJ, Mun AR, et al: Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells. J Ethnopharmacol. 141:1071–1076. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YH, Park KH and Rho HM: Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem. 271:24539–24543. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Chang MS, Lee SG and Rho HM: Transcriptional activation of Cu/Zn superoxide dismutase and catalase genes by panaxadiol ginsenosides extracted from Panax ginseng. Phytother Res. 13:641–644. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kim ND, Pokharel YR and Kang KW: Ginsenoside Rd enhances glutathione levels in H4IIE cells via NF-kappaB-dependent gamma-glutamylcysteine ligase induction. Pharmazie. 62:933–936. 2007.PubMed/NCBI | |
|
Lee SH, Seo GS, Ko G, Kim JB and Sohn DH: Anti-inflammatory activity of 20(S)-protopanaxadiol: enhanced heme oxygenase 1 expression in RAW 264.7 cells. Planta Med. 71:1167–1170. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Saw CL, Yang AY, Cheng DC, et al: Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations. Chem Res Toxicol. 25:1574–1580. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shin YM, Jung HJ, Choi WY and Lim CJ: Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines. Mol Biol Rep. 40:269–279. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kim TW, Joh EH, Kim B and Kim DH: Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. Int Immunopharmacol. 12:110–116. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Joh EH, Lee IA, Jung IH and Kim DH: Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation. Biochem Pharmacol. 82:278–286. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang XL, Guo TK, Wang YH, et al: Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis. Int Immunopharmacol. 12:408–414. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Park EK, Shin YW, Lee HU, et al: Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull. 28:652–656. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Oh GS, Pae HO, Choi BM, et al: 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 205:23–29. 2004. View Article : Google Scholar | |
|
Huang J, Ding L, Shi D, et al: Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E2 production in HaCaT cells. J Pharm Pharmacol. 64:252–258. 2012. View Article : Google Scholar | |
|
Huang J, Qiu L, Ding L, et al: Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE2 production in a human keratinocyte cell line HaCaT. Int Immunopharmacol. 10:1279–1283. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu WK, Xu SX and Che CT: Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67:1297–1306. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang JW, Chen XM, Chen XH and Zheng SS: Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol. 17:3605–3613. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Park HM, Kim SJ, Kim JS and Kang HS: Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol. 50:2736–2741. 2012. View Article : Google Scholar | |
|
Zhang C, Liu L, Yu Y, Chen B, Tang C and Li X: Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep. 5:1295–1298. 2012.PubMed/NCBI | |
|
Yuan HD, Quan HY, Zhang Y, Kim SH and Chung SH: 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway. Mol Med Rep. 3:825–831. 2010.PubMed/NCBI | |
|
Lee JY, Jung KH, Morgan MJ, et al: Sensitization of TRAIL-induced cell death by 20S-Ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol Cancer Ther. 12:274–285. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim BJ, Nah SY, Jeon JH, So I and Kim SJ: Transient receptor potential melastatin 7 channels are involved in ginsenoside Rg3-induced apoptosis in gastric cancer cells. Basic Clin Pharmacol Toxicol. 109:233–239. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Peng H, Ou-Yang X and He X: Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res. 18:322–329. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Li B, Zhao J, Wang CZ, et al: Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 301:185–192. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Choi S, Oh JY and Kim SJ: Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J Cell Biochem. 112:330–340. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim HE, Oh JH, Lee SK and Oh YJ: Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway. Life Sci. 65:PL33–PL40. 1999.PubMed/NCBI | |
|
Kim YS, Jin SH, Lee YH, Kim SI and Park JD: Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL, or Bax in C6Bu-1 cells. Arch Pharm Res. 22:448–453. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Park JA, Lee KY, Oh YJ, Kim KW and Lee SK: Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett. 121:73–81. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Popovich DG and Kitts DD: Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2. Can J Physiol Pharmacol. 82:183–190. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Oh M, Choi YH, Choi S, et al: Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol. 14:869–875. 1999.PubMed/NCBI | |
|
Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM and Hsu SL: Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol. 55:531–540. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Oh JI, Chun KH, Joo SH, Oh YT and Lee SK: Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells. Cancer Lett. 230:228–238. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ham YM, Lim JH, Na HK, et al: Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells. J Pharmacol Exp Ther. 319:1276–1285. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Park EK, Lee EJ, Lee SH, et al: Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt. Br J Pharmacol. 160:1212–1223. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yi JS, Choo HJ, Cho BR, et al: Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption. Biochem Biophys Res Commun. 385:154–159. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
An IS, An S, Kwon KJ, Kim YJ and Bae S: Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells. Oncol Rep. 29:523–528. 2013.PubMed/NCBI | |
|
Wu N, Wu GC, Hu R, Li M and Feng H: Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol Sin. 32:345–353. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Park TY, Park MH, Shin WC, et al: Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull. 31:1802–1805. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kang JH, Song KH, Woo JK, et al: Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells. Plant Foods Hum Nutr. 66:298–305. 2011. | |
|
Kumar A, Kumar M, Park TY, et al: Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis. Int J Mol Med. 24:381–386. 2009.PubMed/NCBI | |
|
Kim JS, Joo EJ, Chun J, et al: Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch Pharm Res. 35:717–722. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YJ, Kwon HC, Ko H, et al: Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol Pharm Bull. 31:826–830. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SE, Lee YH, Park JH and Lee SK: Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res. 19:487–491. 1999.PubMed/NCBI | |
|
Wang W, Wang H, Rayburn ER, Zhao Y, Hill DL and Zhang R: 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer. 98:792–802. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Park S, Lee HJ, Jeong SJ, et al: Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells. Food Chem Toxicol. 49:1367–1372. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sathishkumar N, Sathiyamoorthy S, Ramya M, Yang DU, Lee HN and Yang DC: Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng. J Enzyme Inhib Med Chem. 27:685–692. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Shimizu K, Yu H, Zhang C, Jin F and Kondo R: Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Fitoterapia. 81:902–905. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dong H, Bai LP, Wong VK, et al: The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives. Molecules. 16:10619–10630. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen QJ, Zhang MZ and Wang LX: Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol Biochem. 26:849–858. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yue PY, Wong DY, Wu PK, et al: The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem Pharmacol. 72:437–445. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Kang X, Yang B, Wang J and Yang F: Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother Radiopharm. 23:647–653. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Xu TM, Xin Y, Cui MH, Jiang X and Gu LP: Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J (Engl). 120:584–588. 2007.PubMed/NCBI | |
|
Zhang Q, Kang X and Zhao W: Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun. 342:824–828. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JW, Jung SY, Kwon YH, et al: Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 13:504–515. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K and Azuma I: Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 17:635–639. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong A, Lee HJ, Jeong SJ, Lee EO, Bae H and Kim SH: Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Biol Pharm Bull. 33:945–950. 2010. View Article : Google Scholar | |
|
Pan XY, Guo H, Han J, et al: Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells. Eur J Pharmacol. 683:27–34. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mochizuki M, Yoo YC, Matsuzawa K, et al: Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 18:1197–1202. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Xu TM, Cui MH, Xin Y, et al: Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin Med J (Engl). 121:1394–1397. 2008.PubMed/NCBI | |
|
Chen XP, Qian LL, Jiang H and Chen JH: Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line. Int J Clin Oncol. 16:519–523. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Iishi H, Tatsuta M, Baba M, et al: Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis. 15:603–611. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Shinkai K, Akedo H, Mukai M, et al: Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res. 87:357–362. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon JH, Choi YJ and Lee SG: Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 679:24–33. 2012. View Article : Google Scholar | |
|
Yoon JH, Choi YJ, Cha SW and Lee SG: Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine. 19:284–292. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SY, Kim DH, Han SJ, Hyun JW and Kim HS: Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem Pharmacol. 74:1642–1651. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ming Y, Chen Z, Chen L, et al: Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-kappaB p65 and reduction of matrix metalloproteinase-2/9. Planta Med. 77:428–433. 2011. View Article : Google Scholar | |
|
Hasegawa H and Uchiyama M: Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med. 64:696–700. 1998. View Article : Google Scholar | |
|
Choo MK, Sakurai H, Kim DH and Saiki I: A ginseng saponin metabolite suppresses tumor necrosis factor-α-promoted metastasis by suppressing nuclear factor-κB signaling in murine colon cancer cells. Oncol Rep. 19:595–600. 2008.PubMed/NCBI | |
|
Kim SM, Lee SY, Yuk DY, et al: Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res. 32:755–765. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SM, Lee SY, Cho JS, et al: Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur J Pharmacol. 631:1–9. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Musende AG, Eberding A, Jia W, Ramsay E, Bally MB and Guns ET: Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer. Prostate. 70:1437–1447. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yang LQ, Wang B, Gan H, et al: Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo. Biopharm Drug Dispos. 33:425–436. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pokharel YR, Kim ND, Han HK, Oh WK and Kang KW: Increased ubiquitination of multidrug resistance 1 by ginsenoside Rd. Nutr Cancer. 62:252–259. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lee CK, Park KK, Chung AS and Chung WY: Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem Toxicol. 50:2565–2574. 2012. | |
|
Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T and Nagata I: Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs. 2:63–67. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Xie X, Eberding A, Madera C, et al: Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol. 175:1926–1931. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jia WW, Bu X, Philips D, et al: Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can J Physiol Pharmacol. 82:431–437. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chae S, Kang KA, Chang WY, et al: Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J Agric Food Chem. 57:5777–5782. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Park SA, Kim EH, Na HK and Surh YJ: KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells. Ann NY Acad Sci. 1095:545–553. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yoo JH, Kwon HC, Kim YJ, Park JH and Yang HO: KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer Lett. 289:99–110. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lee WH, Choi JS, Kim HY, et al: Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation. Cancer Lett. 294:74–81. 2010. View Article : Google Scholar | |
|
Tatsuka M, Maeda M and Ota T: Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2). Jpn J Cancer Res. 92:1184–1189. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong HG, Pokharel YR, Han EH and Kang KW: Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein. Biochem Biophys Res Commun. 359:51–56. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JH, Park CY and Lee SJ: Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial. J Clin Pharm Ther. 31:331–334. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lu P, Su W, Miao ZH, Niu HR, Liu J and Hua QL: Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chin J Integr Med. 14:33–36. 2008. View Article : Google Scholar : PubMed/NCBI |
